The estimated Net Worth of Leland Gershell is at least 315$ dollars as of 16 March 2016. Leland Gershell owns over 2,100 units of Tonix Pharmaceuticals Corp stock worth over 315$ and over the last 12 years Leland sold TNXP stock worth over 0$.
Leland has made over 8 trades of the Tonix Pharmaceuticals Corp stock since 2013, according to the Form 4 filled with the SEC. Most recently Leland bought 2,100 units of TNXP stock worth 5,040$ on 16 March 2016.
The largest trade Leland's ever made was buying 5,000 units of Tonix Pharmaceuticals Corp stock on 9 February 2015 worth over 29,250$. On average, Leland trades about 633 units every 57 days since 2013. As of 16 March 2016 Leland still owns at least 2,100 units of Tonix Pharmaceuticals Corp stock.
You can see the complete history of Leland Gershell stock trades at the bottom of the page.
Leland's mailing address filed with the SEC is C/O TONIX PHARMACEUTICALS HOLDING CORP, 509 MADISON AVE., STE 306, NEW YORK, NY, 10022.
Over the last 12 years, insiders at Tonix Pharmaceuticals Corp have traded over 155,884$ worth of Tonix Pharmaceuticals Corp stock and bought 1,820,071 units worth 3,399,062$ . The most active insiders traders include Ernest Mario、Seth Lederman、Bruce Daugherty. On average, Tonix Pharmaceuticals Corp executives and independent directors trade stock every 32 days with the average trade being worth of 2,734$. The most recent stock trade was executed by Seth Lederman on 29 June 2022, trading 20,000 units of TNXP stock currently worth 34,200$.
tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.
Tonix Pharmaceuticals Corp executives and other stock owners filed with the SEC include: